NCT04170296 - Real World CCH Study in Adult Females With Cellulite | Biotech Hunter

Enrollment

153

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

October 6, 2020

Study Completion Date

January 8, 2021

Conditions

Edematous Fibrosclerotic Panniculopathy (EFP)Cellulite

Interventions

DRUG

EN3835

Collagenase Clostridium Histolyticum (CCH)

Trial Locations (12)

Endo Clinical Trial Site #6, New York

Endo Clinical Trial Site #10, Alpharetta

Endo Clinical Trial Site #1, Coral Gables

Endo Clinical Trial Site #12, Nashville

Endo Clinical Trial Site #11, Itasca

Endo Clinical Trial Site #3, Chicago

Endo Clinical Trial Site #8, New Orleans

Endo Clinical Trial Site #2, Encino

Endo Clinical Trial Site #5, Solana Beach

Endo Clinical Trial Site #4, San Diego

Endo Clinical Trial Site #9, Westport

Endo Clinical Trial Site #7, San Juan